Benoit Blondeau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Benoit Blondeau has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Frederick Bolles Rogers
Regions Hospital
9 shared publications - Nicholas James Larson
Regions Hospital
9 shared publications - David J. Dries
Regions Hospital
3 shared publications - Abigail Rebecca Rhone
Department of Surgery, Regions Hospital, Saint Paul, MN, USA
2 shared publications - Barbara A. Olson-Bullis
Division of Research and Evaluation, HealthPartners Institute
2 shared publications David J. Dries
Regions Hospital
2 shared publications
Latest Publications
- 12 October 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
The Role of Decompressive Craniectomy for Severe Refractory Head Injury
Decompressive craniectomy is a potential therapeutic option for patients with severe traumatic brain injury and refractory intracranial hypertension, although its indications and clinical benefits remain controversial. A total of 4060 articles were identified, with 94.6% published after 2010. Several major randomized clinical trials have shaped current understanding of decompressive craniectomy, including the RESCUE-ASDH for primary intracranial hypertension, and the DECRA and RESCUEicp for secondary intracranial hypertension. RESCUE-ASDH and DECRA showed no overall benefit and suggested potential harm associated with decompressive craniectomy. RESCUEicp trial showed reduced mortality and sustained long-term improvement in a subset of patients, although many survivors remained in a dependent state. Critical appraisal of the inclusion and exclusion criteria of these trials, together with supporting evidence from animal studies, suggest that decompressive craniectomy should not be treated as primary intervention for traumatic brain injury. Instead, it may be more appropriately used as an adjunct procedure to prevent worsening cerebral edema following other neurosurgical interventions − such as evaluation of contusions or hematomas − when the operative hemisphere is tight and swollen. Decompressive craniectomy performed solely to control refractory intracranial hypertension in traumatic brain injury is unlikely to provide meaningful patient-centered benefit. Its role as an adjunct procedure after evacuation of contusions or hematomas remains uncertain, particularly in patients with a low predicted risk of unfavorable outcome. Decision regarding decompressive craniectomy should incorporate shared decision making and reflect careful consideration of the functional outcomes acceptable to patients and their families.
- 12 October 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
The Role of Decompressive Craniectomy for Severe Refractory Head Injury
Decompressive craniectomy is a potential therapeutic option for patients with severe traumatic brain injury and refractory intracranial hypertension, although its indications and clinical benefits remain controversial. A total of 4060 articles were identified, with 94.6% published after 2010. Several major randomized clinical trials have shaped current understanding of decompressive craniectomy, including the RESCUE-ASDH for primary intracranial hypertension, and the DECRA and RESCUEicp for secondary intracranial hypertension. RESCUE-ASDH and DECRA showed no overall benefit and suggested potential harm associated with decompressive craniectomy. RESCUEicp trial showed reduced mortality and sustained long-term improvement in a subset of patients, although many survivors remained in a dependent state. Critical appraisal of the inclusion and exclusion criteria of these trials, together with supporting evidence from animal studies, suggest that decompressive craniectomy should not be treated as primary intervention for traumatic brain injury. Instead, it may be more appropriately used as an adjunct procedure to prevent worsening cerebral edema following other neurosurgical interventions − such as evaluation of contusions or hematomas − when the operative hemisphere is tight and swollen. Decompressive craniectomy performed solely to control refractory intracranial hypertension in traumatic brain injury is unlikely to provide meaningful patient-centered benefit. Its role as an adjunct procedure after evacuation of contusions or hematomas remains uncertain, particularly in patients with a low predicted risk of unfavorable outcome. Decision regarding decompressive craniectomy should incorporate shared decision making and reflect careful consideration of the functional outcomes acceptable to patients and their families.
- 8 September 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Etiology Matters: A Systematic Review and Meta-Analysis of Incidence and Outcomes in Abdominal Compartment Syndrome
Objective: To determine if abdominal compartment syndrome (ACS) is a homogenous clinical entity, or if incidence and outcomes after ACS differ by precipitating cause. Data Sources: MEDLINE, Cochrane Reviews, Science Direct, and relevant articles identified through citation matching from January 2018 to January 2026. Study Selection: Adult patients (≥18 years old) diagnosed with ACS. For the metaanalysis, outcomes were compared between those with ACS (experimental group) and those without ACS (controls). Data Extraction: This study was conducted in accordance with PRISMA guidelines. Dual independent review was conducted to screen studies at the abstract, full text, then outcome extraction level. After completion, all data was validated by a senior reviewer to ensure alignment with criteria. Data Synthesis: A total of 100 manuscripts met inclusion criteria for data extraction, 33 reporting mortality, 90 reporting incidence of ACS, and a total of 21 studies included for meta-analysis of mortality. Total incidence of ACS was 0.05% across 1,176,638 unique patients, ranging from 15.16% in patients with moderate/severe pancreatitis to 0.22% in trauma patients. The unadjusted association between ACS and mortality varied by pathology, ranging from no observed association in ECMO patients to a moderate association in trauma patients (odds ratio [OR] 3.15; 95% CI 2.24, 4.43) and large association in nontrauma patients (OR 8.60; 95% CI 4.60, 16.07). Conclusions: Current literature related to ACS suggests that despite a similar underlying pathophysiology, ACS is a unique entity varying by precipitating cause. Future research should identify if treatment algorithms should consider the underlying disease state when managing ACS.
- 8 September 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Etiology Matters: A Systematic Review and Meta-Analysis of Incidence and Outcomes in Abdominal Compartment Syndrome
Objective: To determine if abdominal compartment syndrome (ACS) is a homogenous clinical entity, or if incidence and outcomes after ACS differ by precipitating cause. Data Sources: MEDLINE, Cochrane Reviews, Science Direct, and relevant articles identified through citation matching from January 2018 to January 2026. Study Selection: Adult patients (≥18 years old) diagnosed with ACS. For the metaanalysis, outcomes were compared between those with ACS (experimental group) and those without ACS (controls). Data Extraction: This study was conducted in accordance with PRISMA guidelines. Dual independent review was conducted to screen studies at the abstract, full text, then outcome extraction level. After completion, all data was validated by a senior reviewer to ensure alignment with criteria. Data Synthesis: A total of 100 manuscripts met inclusion criteria for data extraction, 33 reporting mortality, 90 reporting incidence of ACS, and a total of 21 studies included for meta-analysis of mortality. Total incidence of ACS was 0.05% across 1,176,638 unique patients, ranging from 15.16% in patients with moderate/severe pancreatitis to 0.22% in trauma patients. The unadjusted association between ACS and mortality varied by pathology, ranging from no observed association in ECMO patients to a moderate association in trauma patients (odds ratio [OR] 3.15; 95% CI 2.24, 4.43) and large association in nontrauma patients (OR 8.60; 95% CI 4.60, 16.07). Conclusions: Current literature related to ACS suggests that despite a similar underlying pathophysiology, ACS is a unique entity varying by precipitating cause. Future research should identify if treatment algorithms should consider the underlying disease state when managing ACS.
- 7 November 2025
- Published by SAGE Publications in Journal of Intensive Care Medicine
Necrotizing Soft Tissue Infections: A Surgical Perspective
Necrotizing soft tissue infections (NSTIs) present a rare but devasting disease process for affected patients. Timely diagnosis and management of this condition is essential for critical care providers to obtain optimal patient outcomes. Given their rarity, NSTIs are often diagnosed late in the disease process, contributing to an increase in morbidity and mortality among these patients. In this review, we discuss how to classify these infections, their risk factors, pathophysiology, clinical presentation, diagnosis, scoring systems and treatment, with an emphasis on surgical management.
- 7 November 2025
- Published by SAGE Publications in Journal of Intensive Care Medicine
Necrotizing Soft Tissue Infections: A Surgical Perspective
Necrotizing soft tissue infections (NSTIs) present a rare but devasting disease process for affected patients. Timely diagnosis and management of this condition is essential for critical care providers to obtain optimal patient outcomes. Given their rarity, NSTIs are often diagnosed late in the disease process, contributing to an increase in morbidity and mortality among these patients. In this review, we discuss how to classify these infections, their risk factors, pathophysiology, clinical presentation, diagnosis, scoring systems and treatment, with an emphasis on surgical management.
- 31 July 2025
- Published by Elsevier in Journal of Surgical Research
- Vol. 314, 114-121
Older Adults Decompensate More Rapidly After Blunt Hollow Viscus Injury Following Motor Vehicle Collisions
- 31 July 2025
- Published by Elsevier in Journal of Surgical Research
- Vol. 314, 114-121
Older Adults Decompensate More Rapidly After Blunt Hollow Viscus Injury Following Motor Vehicle Collisions
- Open Access
- 15 January 2025
- Published by National EMS Management Association in International Journal of Paramedicine
- No. 9,p. 43-62
Fluid Resuscitation in the Prehospital Setting
Urban Emergency Medical Services benefit from an increased number of higher-level personnel (Advanced Emergency Medical Technicians and Paramedics) responding to all calls that are trained to obtain intravenous access. Current Advanced Trauma Life Support guidelines require all trauma patients to receive intravenous access, and as such it is essential for EMS clinicians to be conversant with situations which may require fluid resuscitation. These situations are especially common in rural or austere environments as long transport times require EMS clinicians to maintain adequate hemodynamics until arrival at a trauma center for definitive care. Historically, crystalloid solutions have been the mainstay of fluid resuscitation with Normal Saline or Lactated Ringer’s solution being preferred. Despite the recent shift in best practices from aggressive fluid resuscitation to delayed or significantly scaled back fluid resuscitation in most settings of trauma, it is essential for EMS clinicians to understand when fluid resuscitation is indicated, or, more importantly, contraindicated. EMS clinicians must be comfortable with the various fluids available to them in the field. This review provides an overview of the most common crystalloid fluids and blood component therapies which may be used for resuscitation in the prehospital setting.
- 15 January 2025
- Published by National EMS Management Association in International Journal of Paramedicine
- No. 9,p. 43-62
Open AccessFluid Resuscitation in the Prehospital Setting
Urban Emergency Medical Services benefit from an increased number of higher-level personnel (Advanced Emergency Medical Technicians and Paramedics) responding to all calls that are trained to obtain intravenous access. Current Advanced Trauma Life Support guidelines require all trauma patients to receive intravenous access, and as such it is essential for EMS clinicians to be conversant with situations which may require fluid resuscitation. These situations are especially common in rural or austere environments as long transport times require EMS clinicians to maintain adequate hemodynamics until arrival at a trauma center for definitive care. Historically, crystalloid solutions have been the mainstay of fluid resuscitation with Normal Saline or Lactated Ringer’s solution being preferred. Despite the recent shift in best practices from aggressive fluid resuscitation to delayed or significantly scaled back fluid resuscitation in most settings of trauma, it is essential for EMS clinicians to understand when fluid resuscitation is indicated, or, more importantly, contraindicated. EMS clinicians must be comfortable with the various fluids available to them in the field. This review provides an overview of the most common crystalloid fluids and blood component therapies which may be used for resuscitation in the prehospital setting.
- 13 April 2024
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 40 (7) , 726-738
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock
Shock is a life-threatening circulatory failure that results in inadequate tissue perfusion and oxygenation. Vasopressors and inotropes are vasoactive medications that are vital in increasing systemic vascular resistance and cardiac contractility, respectively, in patients presenting with shock. To be well versed in using these agents is an important skill to have in the critical care setting where patients can frequently exhibit symptoms of shock. In this review, we will discuss the pathophysiological mechanisms of shock and evaluate the current evidence behind the management of shock with an emphasis on vasopressors and inotropes.
- 13 April 2024
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 40 (7) , 726-738
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock
Shock is a life-threatening circulatory failure that results in inadequate tissue perfusion and oxygenation. Vasopressors and inotropes are vasoactive medications that are vital in increasing systemic vascular resistance and cardiac contractility, respectively, in patients presenting with shock. To be well versed in using these agents is an important skill to have in the critical care setting where patients can frequently exhibit symptoms of shock. In this review, we will discuss the pathophysiological mechanisms of shock and evaluate the current evidence behind the management of shock with an emphasis on vasopressors and inotropes.
- 1 March 2024
- Published by Wolters Kluwer Health in Journal of Trauma Nursing
- Vol. 31 (2) , 57-62
So You Want to Do Trauma Research? A Practical Guide to Creating a Research Program at Your Home Institution
BACKGROUND: There are 3 pillars upon which the foundation of a teaching program in health care is founded: research, education, and clinical care. However, in a busy academic trauma practice, the unfortunate reality is that research is often a low priority in the frenzy of mandates for clinical productivity. OBJECTIVE: The purpose of this report is to advise hospitals on how to create a modest trauma research program that supports research interests without significantly impacting the overall clinical productivity of the department. METHODS: Relevant literature related to the development of an academic trauma research department was reviewed. Relevant articles were then compared to this manuscript to assess the novelty of the topic. RESULTS: There are 4 essential components of a trauma research program: (1) a zealot, (2) institutional commitment and support, (3) a statistician, and (4) registry data access. CONCLUSION: The creation of a trauma research program may seem like a herculean effort, but this work is necessary for institutions hoping to achieve status as a Level I/II trauma center. Following the steps outlined in this report, trauma providers can create a robust research program at their institution without sacrificing clinical productivity.
- 1 March 2024
- Published by Wolters Kluwer Health in Journal of Trauma Nursing
- Vol. 31 (2) , 57-62
So You Want to Do Trauma Research? A Practical Guide to Creating a Research Program at Your Home Institution
BACKGROUND: There are 3 pillars upon which the foundation of a teaching program in health care is founded: research, education, and clinical care. However, in a busy academic trauma practice, the unfortunate reality is that research is often a low priority in the frenzy of mandates for clinical productivity. OBJECTIVE: The purpose of this report is to advise hospitals on how to create a modest trauma research program that supports research interests without significantly impacting the overall clinical productivity of the department. METHODS: Relevant literature related to the development of an academic trauma research department was reviewed. Relevant articles were then compared to this manuscript to assess the novelty of the topic. RESULTS: There are 4 essential components of a trauma research program: (1) a zealot, (2) institutional commitment and support, (3) a statistician, and (4) registry data access. CONCLUSION: The creation of a trauma research program may seem like a herculean effort, but this work is necessary for institutions hoping to achieve status as a Level I/II trauma center. Following the steps outlined in this report, trauma providers can create a robust research program at their institution without sacrificing clinical productivity.
- 19 November 2023
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 40 (3) , 223-230
The State of the Union: Trauma System Development in the United States
Injury is both a national and international epidemic that affects people of all age, race, religion, and socioeconomic class. Injury was the fourth leading cause of death in the United States (U.S.) in 2021 and results in an incalculable emotional and financial burden on our society. Despite this, when prevention fails, trauma centers allow communities to prepare to care for the traumatically injured patient. Using lessons learned from the military, trauma care has grown more sophisticated in the last 50 years. In 1966, the first civilian trauma center was established, bringing management of injury into the new age. Now, the American College of Surgeons recognizes 4 levels of trauma centers (I-IV), with select states recognizing Level V trauma centers. The introduction of trauma centers in the U.S. has been proven to reduce morbidity and mortality for the injured patient. However, despite the proven benefits of trauma centers, the U.S. lacks a single, unified, trauma system and instead operates within a “system of systems” creating vast disparities in the level of care that can be received, especially in rural and economically disadvantaged areas. In this review we present the history of trauma system development in the U.S, define the different levels of trauma centers, present evidence that trauma systems and trauma centers improve outcomes, outline the current state of trauma system development in the U.S, and briefly mention some of the current challenges and opportunities in trauma system development in the U.S. today.
- 19 November 2023
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 40 (3) , 223-230
The State of the Union: Trauma System Development in the United States
Injury is both a national and international epidemic that affects people of all age, race, religion, and socioeconomic class. Injury was the fourth leading cause of death in the United States (U.S.) in 2021 and results in an incalculable emotional and financial burden on our society. Despite this, when prevention fails, trauma centers allow communities to prepare to care for the traumatically injured patient. Using lessons learned from the military, trauma care has grown more sophisticated in the last 50 years. In 1966, the first civilian trauma center was established, bringing management of injury into the new age. Now, the American College of Surgeons recognizes 4 levels of trauma centers (I-IV), with select states recognizing Level V trauma centers. The introduction of trauma centers in the U.S. has been proven to reduce morbidity and mortality for the injured patient. However, despite the proven benefits of trauma centers, the U.S. lacks a single, unified, trauma system and instead operates within a “system of systems” creating vast disparities in the level of care that can be received, especially in rural and economically disadvantaged areas. In this review we present the history of trauma system development in the U.S, define the different levels of trauma centers, present evidence that trauma systems and trauma centers improve outcomes, outline the current state of trauma system development in the U.S, and briefly mention some of the current challenges and opportunities in trauma system development in the U.S. today.
- 4 January 2023
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 38 (4) , 327-339
Comprehensive Review of Current Pain Management in Rib Fractures With Practical Guidelines for Clinicians
Rib fractures are present in 15% of all traumas and 60% of patients with chest traumas. Rib fractures are not life-threatening in isolation, but they can be quite painful which leads to splinting and compromise of respiratory function. Splinting limits the ability of a patient to take a deep breath, which leads to atelectasis, atelectasis to poor secretion removal, and poor secretion removal leads to pneumonia. Pneumonia is the common pathway to respiratory failure in patients with rib fractures. It is noted that in the elderly, each rib fracture increases developing pneumonia by 27% and the risk of dying by 19%. From a public health perspective, rib fractures have long-term implications with only 59% of patients returning to work at 6 months. In this review we will examine the state of art as it currently exists with regard to the management of pain associated with rib fractures. Included in this overview will be a brief review of the anatomy of the thorax and some important physiologic concepts, the latest trends in pharmacologic and noninvasive means of managing rib pain, a special section on epidural anesthesia, some other alternative invasive methods of pain control, and a review of the recent literature on rib plating. Finally, a practical, easy to follow guideline, to manage the patient with pain from rib fractures will be presented.
- 4 January 2023
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 38 (4) , 327-339
Comprehensive Review of Current Pain Management in Rib Fractures With Practical Guidelines for Clinicians
Rib fractures are present in 15% of all traumas and 60% of patients with chest traumas. Rib fractures are not life-threatening in isolation, but they can be quite painful which leads to splinting and compromise of respiratory function. Splinting limits the ability of a patient to take a deep breath, which leads to atelectasis, atelectasis to poor secretion removal, and poor secretion removal leads to pneumonia. Pneumonia is the common pathway to respiratory failure in patients with rib fractures. It is noted that in the elderly, each rib fracture increases developing pneumonia by 27% and the risk of dying by 19%. From a public health perspective, rib fractures have long-term implications with only 59% of patients returning to work at 6 months. In this review we will examine the state of art as it currently exists with regard to the management of pain associated with rib fractures. Included in this overview will be a brief review of the anatomy of the thorax and some important physiologic concepts, the latest trends in pharmacologic and noninvasive means of managing rib pain, a special section on epidural anesthesia, some other alternative invasive methods of pain control, and a review of the recent literature on rib plating. Finally, a practical, easy to follow guideline, to manage the patient with pain from rib fractures will be presented.
- 1 April 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 18 (4) , e452-e461
Cancer Provider and Survivor Experiences With Telehealth During the COVID-19 Pandemic
PURPOSE: The COVID-19 pandemic led to rapid shifts in cancer survivorship care, including the widespread use of telehealth. Given the swift transition and limited data on preferences and experiences around telehealth, we surveyed oncology providers and post-treatment survivors to better understand experiences with the transition to telehealth. METHODS: We distributed provider (MD, PA or NP, nurse, navigator, and social worker) and survivor surveys through the American College of Surgeons Commission on Cancer in mid-October 2020. Survivor surveys were also disseminated through patient advocacy organizations. We included questions on demographics, experiences with telehealth, and preferences for future telehealth utilization. RESULTS: Among N = 607 providers and N = 539 cancer survivors, there was overwhelmingly more support from providers than from survivors for delivery of various types of survivorship care via telehealth and greater comfort with telehealth technologies. The only types of appointments deemed appropriate for survivorship care by both > 50% of providers and survivors were discussion of laboratory results or imaging, assessment and/or management of cancer treatment symptoms, nutrition counseling, and patient navigation support. Only a quarter of survivors reported increased access to health care services (25.5%), and 32.0% reported that they would use telehealth again. CONCLUSION: Although there have been drastic changes in technological capabilities and billing reimbursement structures for telehealth, there are still concerns around delivery of a broad range of survivorship care services via telehealth, particularly from the patient perspective. Still, offering telehealth services, where endorsed by providers and if available and acceptable to cancer survivors, may provide more efficient and accessible care following the COVID-19 pandemic.
- 1 April 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 18 (4) , e452-e461
Cancer Provider and Survivor Experiences With Telehealth During the COVID-19 Pandemic
PURPOSE: The COVID-19 pandemic led to rapid shifts in cancer survivorship care, including the widespread use of telehealth. Given the swift transition and limited data on preferences and experiences around telehealth, we surveyed oncology providers and post-treatment survivors to better understand experiences with the transition to telehealth. METHODS: We distributed provider (MD, PA or NP, nurse, navigator, and social worker) and survivor surveys through the American College of Surgeons Commission on Cancer in mid-October 2020. Survivor surveys were also disseminated through patient advocacy organizations. We included questions on demographics, experiences with telehealth, and preferences for future telehealth utilization. RESULTS: Among N = 607 providers and N = 539 cancer survivors, there was overwhelmingly more support from providers than from survivors for delivery of various types of survivorship care via telehealth and greater comfort with telehealth technologies. The only types of appointments deemed appropriate for survivorship care by both > 50% of providers and survivors were discussion of laboratory results or imaging, assessment and/or management of cancer treatment symptoms, nutrition counseling, and patient navigation support. Only a quarter of survivors reported increased access to health care services (25.5%), and 32.0% reported that they would use telehealth again. CONCLUSION: Although there have been drastic changes in technological capabilities and billing reimbursement structures for telehealth, there are still concerns around delivery of a broad range of survivorship care services via telehealth, particularly from the patient perspective. Still, offering telehealth services, where endorsed by providers and if available and acceptable to cancer survivors, may provide more efficient and accessible care following the COVID-19 pandemic.